» Articles » PMID: 29515517

Cushing's Syndrome and Hypothalamic-Pituitary-Adrenal Axis Hyperactivity in Chronic Central Serous Chorioretinopathy

Overview
Specialty Endocrinology
Date 2018 Mar 9
PMID 29515517
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Central serous chorioretinopathy (CSC), a specific form of macular degeneration, has been reported as presenting manifestation of Cushing's syndrome. Furthermore, CSC has been associated with both exogenous hypercortisolism and endogenous Cushing's syndrome. It is important to know whether CSC patients should be screened for Cushing's syndrome. Although hypothalamic-pituitary-adrenal (HPA) axis hyperactivity in CSC has been suggested, no detailed evaluation of the HPA axis has been performed in a large cohort of CSC patients. This study aimed to investigate whether Cushing's syndrome prevalence is increased among chronic CSC (cCSC) patients and whether detailed endocrinological phenotyping indicates hyperactivity of the HPA axis.

Design: Cross-sectional study.

Patients: 86 cCSC patients and 24 controls.

Measurements: Prevalence of Cushing's syndrome, HPA axis activity.

Results: None of the cCSC patients met the clinical or biochemical criteria of Cushing's syndrome. However, compared to controls, HPA axis activity was increased in cCSC patients, reflected by higher 24 h urinary free cortisol, and accompanying higher waist circumference and diastolic blood pressure, whereas circadian cortisol rhythm and feedback were not different. Chronic CSC patients did not report more stress or stress-related problems on questionnaires.

Conclusion: No case of Cushing's syndrome was revealed in a large cohort of cCSC patients. Therefore, we advise against screening for Cushing's syndrome in CSC patients, unless additional clinical features are present. However, our results indicate that cCSC is associated with hyperactivity of the HPA axis, albeit not accompanied with perception of more psychosocial stress.

Citing Articles

Psychometric assessment of patients with central serous chorioretinopathy and correlation with disease stage and progression: a case control study.

Hufnagel H, Lahmann C, Agostini H, Lange C, Pauleikhoff L BMC Ophthalmol. 2024; 24(1):92.

PMID: 38424605 PMC: 10902987. DOI: 10.1186/s12886-024-03356-2.


Hemostatic profiles in dogs with sudden acquired retinal degeneration syndrome.

Lynch A, Ruterbories L, Robertson J, Lunn K, Mowat F J Vet Intern Med. 2023; 37(3):948-959.

PMID: 37073895 PMC: 10229342. DOI: 10.1111/jvim.16710.


Central serous chorioretinopathy: Pathophysiology, systemic associations, and a novel etiological classification.

Jain M, Mohan S, van Dijk E Taiwan J Ophthalmol. 2023; 12(4):381-393.

PMID: 36660127 PMC: 9843580. DOI: 10.4103/2211-5056.362601.


Cortisol awake response imbalance as an indicator of acute central serous chorioretinopathy: Relationship with choriocapillaris and choroidal features.

Scarinci F, Patacchioli F, Costanzo E, Parravano M Front Med (Lausanne). 2022; 9:1030352.

PMID: 36530871 PMC: 9748141. DOI: 10.3389/fmed.2022.1030352.


Effects of Ketoconazole on the Clinical Recovery in Central Serous Chorioretinopathy.

Chantarasorn Y, Rasmidatta K, Pokawattana I, Silpa-Archa S Clin Ophthalmol. 2022; 16:1871-1882.

PMID: 35711967 PMC: 9192783. DOI: 10.2147/OPTH.S368427.


References
1.
Bastien C, Vallieres A, Morin C . Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med. 2001; 2(4):297-307. DOI: 10.1016/s1389-9457(00)00065-4. View

2.
Thoelen A, Bernasconi P, Schmid C, Messmer E . Central serous chorioretinopathy associated with a carcinoma of the adrenal cortex. Retina. 2000; 20(1):98-9. DOI: 10.1097/00006982-200001000-00020. View

3.
Bouzas E, Scott M, Mastorakos G, Chrousos G . Central serous chorioretinopathy in endogenous hypercortisolism. Arch Ophthalmol. 1993; 111(9):1229-33. DOI: 10.1001/archopht.1993.01090090081024. View

4.
Cohen S, Kamarck T, Mermelstein R . A global measure of perceived stress. J Health Soc Behav. 1983; 24(4):385-96. View

5.
Wakakura M, Song E, Ishikawa S . Corticosteroid-induced central serous chorioretinopathy. Jpn J Ophthalmol. 1997; 41(3):180-5. DOI: 10.1016/s0021-5155(97)00027-0. View